Log in to save to my catalogue

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4787218

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease

About this item

Full title

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2016-03, Vol.13 (1), p.61-61, Article 61

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Docosahexaenoic acid (DHA) is an omega-3 (ω-3) long-chain polyunsaturated fatty acid (LCPUFA) relevant for brain function. It has largely been explored as a potential candidate to treat Alzheimer's disease (AD). Clinical evidence favors a role for DHA in the improvement of cognition in very early stages of the AD. In response to stress or damage, D...

Alternative Titles

Full title

Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4787218

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4787218

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-016-0525-7

How to access this item